Corrêa Jessica Audrey Feijó, de Melo Nazareth Tiago, Rocha Giovanna Fernandes da, Luciano Fernando Bittencourt
Laboratory of Agri-Food Research and Innovation, School of Medicine and Life Sciences, Pontifícia Universidade Católica do Paraná, R. Imaculada Conceição 1155, Curitiba 80215-901, Brazil.
Laboratory of Food Chemistry and Toxicology, Faculty of Pharmacy, University of Valencia, Av. Vicent Andrés Estellés s/n, 46100 Burjassot, Spain.
Pathogens. 2023 Mar 17;12(3):477. doi: 10.3390/pathogens12030477.
Bioactive peptides (BAPs) derived from food proteins have been extensively studied for their health benefits, majorly exploring their potential use as nutraceuticals and functional food components. These peptides possess a range of beneficial properties, including antihypertensive, antioxidant, immunomodulatory, and antibacterial activities, and are naturally present within dietary protein sequences. To release food-grade antimicrobial peptides (AMPs), enzymatic protein hydrolysis or microbial fermentation, such as with lactic acid bacteria (LAB), can be employed. The activity of AMPs is influenced by various structural characteristics, including the amino acid composition, three-dimensional conformation, liquid charge, putative domains, and resulting hydrophobicity. This review discusses the synthesis of BAPs and AMPs, their potential for controlling foodborne pathogens, their mechanisms of action, and the challenges and prospects faced by the food industry. BAPs can regulate gut microbiota by promoting the growth of beneficial bacteria or by directly inhibiting pathogenic microorganisms. LAB-promoted hydrolysis of dietary proteins occurs naturally in both the matrix and the gastrointestinal tract. However, several obstacles must be overcome before BAPs can replace antimicrobials in food production. These include the high manufacturing costs of current technologies, limited in vivo and matrix data, and the difficulties associated with standardization and commercial-scale production.
源自食物蛋白质的生物活性肽(BAPs)因其对健康的益处而受到广泛研究,主要探索其作为营养保健品和功能性食品成分的潜在用途。这些肽具有一系列有益特性,包括抗高血压、抗氧化、免疫调节和抗菌活性,并且天然存在于膳食蛋白质序列中。为了释放食品级抗菌肽(AMPs),可以采用酶促蛋白质水解或微生物发酵,如使用乳酸菌(LAB)。AMPs的活性受多种结构特征影响,包括氨基酸组成、三维构象、净电荷、假定结构域以及由此产生的疏水性。本综述讨论了BAPs和AMPs的合成、它们控制食源性病原体的潜力、作用机制以及食品工业面临的挑战和前景。BAPs可通过促进有益细菌生长或直接抑制病原微生物来调节肠道微生物群。LAB促进的膳食蛋白质水解在基质和胃肠道中自然发生。然而,在BAPs能够在食品生产中替代抗菌剂之前,必须克服几个障碍。这些障碍包括当前技术的高制造成本、有限的体内和基质数据,以及与标准化和商业规模生产相关的困难。